RARE logo
RARE

Ultragenyx Pharmaceutical Inc

Biotechnology

Ultragenyx Pharmaceutical Inc (RARE) Financials

We don't have SEC-filed financials for RARE yet. Explore its overview, insider activity, and news below.

Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.